Astrana Health (ASTH) Cost of Revenue (2010 - 2026)

Astrana Health's Cost of Revenue history runs 17 years deep, the most recent figure standing at $859.4 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 56.51% year-over-year to $859.4 million; the TTM figure through Mar 2026 stood at $3.2 billion (up 58.97% YoY), while the FY2025 annual figure was $2.8 billion, up 61.09% from the prior year.
• Cost of Revenue came in at $859.4 million for Q1 2026 at Astrana Health, roughly flat from $855.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $859.4 million in Q1 2026 to a low of $220.7 million in Q1 2022.
• A 5-year average of $445.8 million and a median of $330.4 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue gained 14.17% in 2024 and surged 111.95% in 2025, its largest moves.
• Astrana Health's Cost of Revenue stood at $253.1 million in 2022, then increased by 24.07% to $314.1 million in 2023, then soared by 95.74% to $614.7 million in 2024, then jumped by 39.16% to $855.5 million in 2025, then climbed by 0.45% to $859.4 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $859.4 million, $855.5 million, and $858.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison